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Two simple and selective spectrophotometric methods have been proposed for the determination of gabapentin (GBP) in pure
form and in capsules. Both methods are based on the proton transfer from the Lewis acid such as 2,4,6-trinitrophenol (picric
acid; PA) or 2,4-dinitrophenol (2,4-DNP) to the primary amino group of GBP which works as Lewis base and formation of
yellow ion-pair complexes. The ion-pair complexes formed show absorption maximum at 415 and 420 nm for PA and 2,4-DNP,
respectively. Under the optimized experimental conditions, Beer’s law is obeyed over the concentration ranges of 1.25–15.0 and
2.0–18.0μgmL
−1 GBP for PA and 2,4-DNP methods, respectively. The molar absorptivity, Sandell’s sensitivity, detection and,
quantiﬁcation limits for both methods are also reported. The proposed methods were applied successfully to the determination
of GBP in pure form and commercial capsules. Statistical comparison of the results was performed using Student’s t-test and F-
ratio at 95% conﬁdence level, and there was no signiﬁcant diﬀerence between the reference and proposed methods with regard
to accuracy and precision. Further, the validity of the proposed methods was conﬁrmed by recovery studies via standard addition
technique.
1.Introduction
Gabapentin (GBP), chemically known as 1-(aminomethyl)
cyclohexaneacetic acid [1], is freely soluble in water as well
as in both basic and acidic aqueous solutions. GBP was
originally developed for the treatment of epilepsy; it is
currently also used against neuropathic pain. Although its
exact mechanism of action is yet unknown, it is believed
to involve voltage-gated N-type calcium ion channels in the
central nervous system, reducing calcium inﬂux into the
nerve terminals [2]. In this way, the nerves become less
excitable, reducing the release of other neurotransmitters.
S e v e r a lt e c h n i q u e sa r ea v a i l a b l ef o rt h ed e t e r m i n a t i o n
of GBP in pharmaceutical preparations and include ﬂuo-
rimetry using sequential injection [2], spectroﬂuorimetry
[3, 4], chemiluminometry [5], high performance liquid
chromatography (HPLC) [6–11], capillary electrophoresis
[12, 13], potentiometric sensor [14], voltammetry [15], visi-
ble spectrophotometry [16–20], UV spectrophotometry [20,
21], and automated spectrophotometry using piezoelectric
pumping [22].
To the best of our knowledge, there are ﬁve reports on
the use of visible spectrophotometry for the determination
of GBP in pharmaceuticals. Abdellatef and khalil [16]h a v e
reported three methods based on three diﬀerent reactions
involving the use of vanillin in the presence of McIlvain
buﬀer pH 7.5, ninhydrin reagent in DMF medium, and p-
benzoquinone in ethanol medium. The method reported by
Al-Zehouri et al. [17] was based on the condensation of GBP
with acetylacetone and formaldehyde according to Hantzsch
reaction. The charge transfer complexation reactions of GBP
as n-electron donor with various acceptors such as iodine,
chloranil, chloranilic acid, DDQ, TCNQ, and TCNE were
reportedbySalem[18].ThereactionofGBPwithninhydrine
in DMF medium has served as the basis of spectropho-
tometric assay reported by Galande et al. [19]. Siddiqui
et al. [20]h a v er e p o r t e dt w od i ﬀerent reactions involving
ninhydrin in methanol medium and TCNQ in acetonitrile.2 International Journal of Analytical Chemistry
Table 1: Chromatographic methods reported for the determination of GBP in pharmaceuticals.
Technique
Chromatographic conditions
LOD, mgmL−1 Range, μgmL −1 Ref.
Mobile phase Flow rate,
mLmin−1
Detection, UV,
nm
(1) HPLC
Ammonium dihydrogen
orthophosphate buﬀer and
methanol in 60:40 (v/v)
1.0 200 NR 2500–7500 [6]
(2) HPLC
Methanol-acetonitrile-
potassium dihydrogen
phosphate (pH 5.2;
0.028M) (25:10:65, v/v)
1.0 210 NR 100–3800 [7]
(3) HPLC
Acetonitrile-sodium
dihydrogenphosphate (pH
2.5; 0.05 M) (70:30, v/v)
1.5 360 NR 10–500 [8]
(4) HPLC
Methanol-potassium
dihydrogen
orthophosphate solution
(20:80, v/v) containing
10% NaOH
1.0 275 NR 940–1060 [9]
(5) HPLC
Acetonitrile-10mM
KH2PO4/10mM K2HPO4
(pH 6.2) (8:92, v/v)
1.0 210 0.005 500–5000 [10]
(6) HPLC
Methanol-acetonitrile-
20mM KH2PO4 (pH 2.2)
(5:5:90, v/v/v)
1.25 210 0.015 50–650 [11]
NR: Not reported.
However, many of the above methods suﬀered from one or
other disadvantage like poor sensitivity, measurements done
at shorter wavelengths, heating or cooling step, the use of
expensive chemical and/or complicated experimental setup
as can be seen from Tables 1 and 2.
The reagents under study, that is, 2,4,6-trinitrophenol
(picric acid; PA) and 2,4-dinitrophenol (2,4-DNP) have
numerous applications as analytical reagents, and they have
been used for the spectrophotometric determination of
m a n yd r u g si np h a r m a c e u t i c a lf o r m u l a t i o n s[ 23–26].
This paper describes the application of PA and 2,4-DNP
to the spectrophotometric determination of GBP in bulk
drug as well as in capsules. The proposed methods are based
ontheformationofion-paircomplexesasaresultofaproton
transfer from PA or 2,4-DNP to the primary amino group
of GBP. The proposed methods have been demonstrated
to be superior to many reported methods with respect to
speed, simplicity, sensitivity and cost eﬀectiveness, and can
be adopted by the pharmaceutical laboratories for industrial
quality control.
2. Experimental
2.1. Instrument. A Systronics model 106 digital spectropho-
tometer (Systronics, Ahmedabad, Gujarat, India) equipped
with 1cm matched quartz cells was used for all absorbance
measurements.
2.2. Materials. Pharmaceutical grade gabapentin (GBP)
which is reported to be 99.5% pure was received from Sun
Pharmaceuticals, Mumbai, India. The following pharmaceu-
tical preparations were purchased from commercial sources
in the local market and subjected to analysis: Gabantin-
100 (100mg GBP per capsule) from Sun Pharma Sikkim,
Ranipool, East Sikkim, India and Gabapin-300 (300mg GBP
per capsule) from Intas Pharmaceuticals, Dehradun, India.
2.3. Reagents and Chemicals. All reagents used were of
analytical reagent grade, and HPLC grade organic solvents
were used throughout the investigation.
A2 . 0 g L −1 PA and 2.0gL−1 2,4-DNP solutions were
prepared separately in dichloromethane for use in method
A and method B, respectively. A stock standard solution
containing 100μgmL −1 GBP was prepared by dissolving
10mg of pure drug in 2.0mL methanol and diluting to the
mark in a 100mL calibratedﬂaskwithacetonitrile. The stock
standard solution was diluted appropriately with acetonitrile
to get working concentrations of 25 and 40μgmL −1 GBP for
use in method A and method B, respectively.
2.4. Assay Procedure
2.4.1.MethodA(UsingPA). Diﬀerentaliquots(0.25–3.0mL)
of a standard GBP (25.0μgmL −1)s o l u t i o nw e r ea c c u r a t e l y
transferred into a series of 5mL calibrated ﬂasks using a
microburette, and the total volume was adjusted to 3.0mL
by adding adequate quantity of acetonitrile. One milliliter of
2.0gL−1 PAsolutionwasaddedtoeachﬂaskandthemixture
was diluted to the volume with acetonitrile and mixed well.
The absorbance of each solution was measured at 415nm
against a reagent blank after 10min.International Journal of Analytical Chemistry 3
Table 2: Comparison of the proposed and the existing visible spectrophotometric methods.
Sl. No. Reagent/s used Methodology λmax(nm)
Linear Range,
μgmL −1 and ε,
lmol −1 cm−1
LOD,
μgmL −1
Reaction
time,
min
Remarks Ref.
(1)
(a) Vanillin Condensation
product measured 376 80–360
(ε = 4.57 × 102) NR 30 Less sensitive,
measurements at
shorter wavelengths
for (a) and (c),
heating required for
(b) and (c).
(b) Ninhydrin Condensation
product measured 569 40–280
(ε = 5.16 × 102) NR 5 [16]
(c) p-benzoquinone Condensation
product measured 369 80–320
(ε = 4.63 × 102) NR 5
(2) Acetylacetone and
formaldehyde
Condensation
product measured 415 20–140
(ε = 1.66 × 103) NR 20 Heating required,
less sensitive
[17]
(3) (a) Iodine Triiodide ion
measured 360 6–30
(ε = 6.19 × 103) 0.39 —
Shorter wavelength
and less sensitive (a)
Expensive reagent
used (b) Less
sensitive
(b) 7,7,8,8-
tetracyano-
quinodimethane
Radical anions
measured 842 8–24
(ε = 7.22 × 103) 0.48 20 [18]
(c) DDQ -do- 456 12–36
(ε = 9.34 × 103) 1.20 —
(d) Chloranilic Acid -do- 535 60–200
(ε = 7.19 × 103) 7.59 —
(e) Tetracyano
ethylene -do- 412 40–140
(ε = 1.10 × 103) 3.54 15
(f) Chloranil -do- 521 40–120
(ε = 1.23 × 103) 3.33 20
(4) Ninhydrin Colored product
measured 405 50–300 NR 5 Heating required,
less sensitive
[19]
(5) (a) Ninhydrin Condensation
product measured 568 2–30
(ε = 1.25 × 104) 0.15 20 [20]
(b) 7,7,8,8-
tetracyano-
quinodimethane
Charge transfer
complex measured 439 4–30
(ε = 6.77 × 104) 0.04 15
Heating require
Expensive reagent
used.
(6) NQS
Automated ﬂow
injection using
piezoelectric
pumping
480 Up to 150 11.0 and
9.8 —
Less sensitive and
complicated
experimental setup
[22]
(7) (a) Picric acid Ion-pair complex
measured 415 1.25–15
(ε = 1.09 × 104) 0.23 10 Simple, sensitive
selective, no heating
step and inexpensive
reagents used.
This
work
(b) 2,4-Dinitrophenol -do- 420 2–18
(ε = 0.64 × 104) 0.75 10
DDQ: 2,3-dicloro-5,6-dicyano-1,4-benzoquinone, NQS: Sodium 1,2-naphthoquinone-4-sulfonate, NR: Not reported.
2.4.2. Method B (Using 2,4-DNP). Aliquots (0.25–2.25mL)
of a standard GBP (40μgmL −1)s o l u t i o nw e r ea c c u r a t e l y
transferredintoaseriesof5mLcalibratedﬂasks,asdescribed
above. To each ﬂask was then added 0.75mL of 2.0gL−12,4-
DNP, and the content was diluted to the volume with
acetonitrileandwasmixedwell.After10min,theabsorbance
was measured at 420nm against a reagent blank prepared
simultaneously.
2.4.3. Procedure for Capsules. The content of ten capsules
each containing 100 or 300mg of GBP was weighed. An
accurately weighed quantity equivalent to 10mg of GBP
was transferred into a 100 mL calibrated ﬂask and dissolved
in 2.0mL methanol followed by the addition of 60mL
acetonitrile. The solution was shaken thoroughly for about
15–20min, diluted to the mark with acetonitrile, mixed well,
and ﬁltered using a Whatman No. 42 ﬁlter paper. The ﬁrst
10mL portion of the ﬁltrate was discarded, and a suitable
aliquot of the ﬁltrate (100μgmL −1 GBP) was diluted to get
the working concentrations of 25 and 40μgmL −1 GBP for
analysisbymethodsAandB,respectively,asdescribedabove.
2.4.4. Procedure for the Selectivity Study. Selectivity was
evaluated by both placebo blank analysis and recovery
studies. A placebo blank, the commonly employed excipients
added to the formulations, consisting of 30mg starch, 20mg
lactose, 20mg acacia, 20mg calcium gluconate, 50mg talc,
30mg magnesium stearate, and 20mg sodium alginate was4 International Journal of Analytical Chemistry
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Figure 1: Absorption spectra of (1) sample versus reagent blank
(7.5μgmL −1 GBP)-method A; (2) reagent blank-method A; (3)
sample versus reagent blank (8.0μgmL −1 GBP)-method B; (4)
reagent blank-method B.
prepared as described under “Procedure for capsules” and
then subjected to analysis.
A synthetic mixture was prepared by adding 10mg of
pure GBP to 50mg of the above mentioned placebo blank,
and the mixture was homogenized. Following the same
procedure for capsules, the synthetic mixture solution was
prepared, and a suitable quantity was subjected for analysis
by both the methods.
2.5. Stoichiometric Relationship. Job’s method of continuous
variations of equimolar solutions was employed to establish
the stoichiometry of the formed ion-pair complexes. The
solutions equivalent to 1.46 × 10−4 and 1.17 × 10−3 M
GBP were prepared by dissolving the calculated amount
of GBP in a minimum amount of methanol and diluting
to volume with acetonitrile. Further, 1.46 × 10−4 MP A
and 1.17 × 10−3 M 2,4-DNP solutions were prepared in
dichloromethane.Aseriesofsolutionswaspreparedinwhich
the total volume of GBP and reagent was kept at 2.5mL in
a total volume of 5mL. The solutions were mixed well; the
volume was completed to the mark with both acetonitrile
and dichloromethane keeping the ratio of the two solvents as
1:1 in each ﬂask. The absorbance of the resulting solutions
was measured after 10min at the respective wavelengths of
maximum absorbance (λmax) against the blank consisted of
(1:1) acetonitrile and dichloromethane.
3. Results andDiscussion
3.1. Absorption Spectra. The reaction of PA or 2,4-DNP as
Lewis acids with GBP as Lewis base results in the formation
of an intense yellow colored products. The absorption
spectra of the yellow colored products were recorded at
Table 3: Regression and analytical parameters.
Parameter Method A Method B
λmax, nm 415 420
Beer’s law limits (μgmL −1)1 . 2 5 −15 2−18
Molar absorptivity
(lmol−1 cm−1) 1.09 × 104 0.64 × 104
Sandell sensitivity∗ (μgcm −2) 0.0158 0.0267
Limit of detection (μgmL −1) 0.23 0.75
Limit of quantiﬁcation
(μgmL −1) 0.71 2.28
Regression equation, Y∗∗= 0.0072 + 0.062X 0.0094 + 0.035X
Correlation coeﬃcient (r) 0.9993 0.9994
Standard deviation of
intercept (Sa) 0.0229 0.0276
Standard deviation of slope
(Sb) 0.0025 0.0026
∗L i m i to fd e t e r m i n a t i o na st h ew e i g h ti nμg per mL of solution, which
corresponds to an absorbance of A = 0.001 measured in a cuvette of cross-
sectional area 1cm2 and l = 1cm.∗∗Y = a+bX, where Y is the absorbance,
a is the intercept, b is the slope, and X is the concentration in μgmL −1.
380–480nm against the corresponding blank solutions.
The resulted yellow colored ion-pair complexes showed
maximum absorbance at 415 and 420nm for GBP-PA and
GBP-2,4-DNP, respectively, (Figure 1).
3.2. Reaction Mechanism. The chemistry used in the pro-
posed methods is based on the proton-transfer from the
h y d r o x y lg r o u po ft h eL e w i sa c i ds u c ha sP Ao r2 , 4 - D N Pt o
the primary amino group of the Lewis base, GBP, resulting
in the formation of yellow colored ion-pair complexes.
Higuchi and Brochmann-Hanssen [27] have reported that
the basic aliphatic amines form salts with picric acid in
organic solvents which are much more intensely colored
than picric acid itself, and this is due to the fact that the
negatively charged picrate ion (phenolate ion) is intensely
colored (yellow), where as the undissociated form, as it
exists in neutral or acidic solvents is very lightly colored.
Similarly, Saito and Matsunaga [28] reported that when the
aliphatic amine is combined with a polynitrophenol, the
fore ﬁeld produces an acid-base interaction which leads to
the formation of true phenolate by proton transfer. The
possible reaction mechanisms are proposed and illustrated
in Figure 2.
3.3. The eﬀect of Diﬀerent Experimental Variables. Some
variables which found to aﬀect the intensity of the resulting
ion-pair complexes were optimized to achieve maximum
analytical sensitivity and adherence to Beer’s law.
3.3.1. Eﬀect of Reagent Concentration. The eﬀect of the
reagent concentration on the intensity of the formed yellow
colored complexes at the selected wavelengths was studied
by measuring the absorbance of solutions containing ﬁxed
concentrations of 8.0 and 10.0μgmL −1 GBP and diﬀerent
amounts (0.25–2.5mL) of the reagents PA and 2,4-DNPInternational Journal of Analytical Chemistry 5
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Figure 2: The probable reaction mechanism for the formation of GBP-PA and GBP-2,4-DNP ion-pair complexes.
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Figure 3: Eﬀect of reagents concentrations on the color develop-
ment: (1) corresponding blank-method A; (2) sample versus corre-
sponding blank (8.0μgmL −1 GBP)-method A; (3) corresponding
blank-method B; (4) sample versus reagent blank (10.0μgmL −1
GBP)-method B.
for methods A and B, respectively. The results showed that
1.0mL of 2.0gL−1 PA and 0.75 mL of 2.0g L−12,4-DNP
solutions were optimum for the production of maximum
and reproducible color intensity (Figure 3).
3.3.2. Eﬀect of Solvent. The eﬀect of diﬀerent solvents to
prepare GBP solution was restricted since its solubility is
limited to a few organic solvents such as methanol and
acetonitrile. Even though GBP is freely soluble in methanol
and less soluble in acetonitrile, methanolic solution of GBP
couldn’t be used in the assay because methanol gave intense
yellow color with PA and 2,4-DNP. So, to prepare the stock
solution, GBP was ﬁrst dissolved in a minimum amount of
methanol and subsequently diluted with acetonitrile. The
results showed that the eﬀect of methanol used to prepare
the stock solution of GBP was negligible.
In order to select the suitable solvent to prepare the
PA and 2,4-DNP solutions, both reagents were prepared
separately in diﬀerent solvents such as 1,4-dioxane, chlo-
roform, acetonitrile, dichloromethane, acetone, benzene,
dichloroethane, and methanol. Then, the reaction of GBP
with PA or 2,4-DNP was carried out in the solvents
mentioned above, and the absorbance of each solution
was measured at the selected wavelengths against the
corresponding blank. In method A, the results showed
that the corresponding blank in methanol gave maximum
absorbance against methanol compared with the sample
for the same solvent against the corresponding blank, and
dichloromethanewastheidealsolventwhichwasﬁnallyused
for the preparation of PA solution (Figure 4). In method B,
as shown in Figure 4, both chloroform and dichloromethane
were found suitable to be used for the preparation of 2,4-
DNP solution, but the latter was preferred due to the high
stability of the measured species compared with the same
in chloroform medium. Also, the eﬀect of the diluting
solvent was tested for both methods, and the results showed
that acetonitrile was the ideal diluting solvent to achieve
maximum sensitivity in both the methods.
3.3.3. Eﬀect of Reaction Time and Stability of the Measured
Species. The optimum reaction time was determined by
following the absorbance of the developed color upon the
addition of PA or 2,4-DNP solution to the GBP solution
at room temperature. For both methods, the reaction was
found to be complete and quantitative when the reaction6 International Journal of Analytical Chemistry
Table 4: Precision and accuracy.
Method
GBP taken
(μgmL −1)
Intraday (n = 7) Interday (n = 5)
GBP founda
(μgmL −1) %RSDb %REc GBP founda
(μgmL −1) %RSDb %REc
Method A
5.00
7.50
10.00
5.13
7.66
10.28
1.54
1.03
1.72
2.60
2.13
2.80
5.16
7.72
10.36
1.42
1.65
2.11
3.20
2.93
3.60
Method B
8.00
12.00
16.00
8.18
12.23
15.82
1.46
2.34
1.98
2.25
1.92
−1.12
8.23
12.28
15.76
1.77
2.59
2.45
2.88
2.33
−1.50
aMean value of n determinations.
bRelative standard deviation (%).
cBias (%): [(found − taken)/taken] × 100.
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Figure 4: Eﬀect of solvents on the color development: (1) corresponding blank-method A; (2) sample versus corresponding blank
(7.5μgmL −1 GBP)-method A; (3) corresponding blank-method B; (4) sample versus reagent blank (7.5μgmL −1 GBP)-method B.
mixture was allowed to stand for 10min, and any delay
in the absorbance measurements of the yellow ion pair
complexes had no eﬀect on the reaction stoichiometry which
was determined to be 1:1 (GBP: reagent) for the ranges
studied. The ion-pair complexes of GBP with PA and 2,4-
DNP, which were used for quantitation of the drug, were
found to be stable up to 48 and 24hrs, respectively.
3.4. Composition of the Ion-Pair Complex. Job’s continuous
variations graph for the reaction between GBP and PA or
2,4-DNP shows that the interaction occurs on an equimolar
basis via the formation of ion-pair complexes (Figure 5). The
plot reached a maximum value at a mole fraction of 0.5
which indicated that a 1:1 (GBP:PA) and (GBP:2,4-DNP)
ion-pair complexes are formed through the electrostatic
attraction between positive protonated GBP and nitrophe-
nolate anions. This ﬁnding was anticipated by the presence
of one basic or electron-donating centre (−NH2) in the
GBP. The conditional stability constants (Kf) of the ion-pair
complexes were calculated [29] from the data of continuous
variations method and found to be 5.73 × 107 and 4.54 ×
105 for GBP-PA and GBP-2,4-DNP complexes, respectively.
T h eh i g hv a l u e so fK f conﬁrm the expected high stabilities
of the formed ion-pair complexes. This parameter is strongly
dependent on the nature of the used acceptor including the
type and number of electron-withdrawing substituents to it
suchasnitrogroups[30].Thisisthereasonforthehighvalue
of Kf of GBP-PA ion-pair complex compared with the same
for 2,4-DNP.
3.5. Method Validation
3.5.1. Linearity. Under the optimized experimental condi-
tions for GBP determination, the standard calibration curves
for GBP with PA and 2,4-DNP were constructed by plot-
ting absorbance versus concentration. The linear regression
equations were obtained by the method of least squares, and
the Beer’s law range, molar absorptivity, Sandell’s sensitivity,
correlation coeﬃcient, standard deviation of intercept (Sa),International Journal of Analytical Chemistry 7
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Figure 5: Job’s Continuous-variations plots (a) GBP + PA; (b) GBP + 2,4-DNP.
Table 5: Method robustness and ruggedness.
Method
GBP Taken
μgmL −1
Robustness (%RSD) Ruggedness (%RSD)
Reagent
volume Reaction time Interanalysts
(n = 3)
Interinstruments
(n = 3)
5.00 1.48 0.76 0.58 2.58
Method A 7.50 1.26 0.85 0.63 1.74
10.00 0.85 1.08 0.87 2.64
8.00 0.68 1.18 0.75 3.03
Method B 12.00 1.12 1.26 1.09 2.86
16.00 1.38 1.56 1.27 3.25
∗In method A, the volume of PA was 0.8, 1.0 and 1.2mL, and the reaction time was 8, 10, and 12min. In method B, the volume of 2,4-DNP added was 0.65,
0.75, and 0.85mL, and the reaction time was 8, 10, and 12min.
standard deviation of slop (Sb), limits of detection, and
quantiﬁcation for both methods are summarized in Table 3.
The limit of detection (LOD) and limit of quantiﬁcation
(LOQ) for the proposed methods were calculated using the
following equations [31]:
LOD =
3.3 × σ
S
,L O Q =
10 × σ
S
,( 1 )
where σ is the standard deviation of n replicate determina-
tions (n = 8 for method A and n = 6 for method B) under
the same conditions as for the sample analysis in the absence
oftheanalyte,andSisthesensitivity, namely,theslopeofthe
calibration graph.
3.5.2. Accuracy and Precision. I no r d e rt oe v a l u a t et h e
precision of the proposed methods, solutions containing
three diﬀerent concentrations of GBP were prepared and
analyzed in seven replicates during the same day (intraday
precision)andﬁveconsecutivedays(interdayprecision),and
the results were summarized in Table 4. The low values of
the percentage relative standard deviation (RSD≤2.34% for
intraday) and (RSD≤2.59% for interday) indicate the high
Table 6: Results of assay of capsules and statistical evaluation.
Capsule brand
name
Found (% of nominal amount ± SD)∗
Reference
method
Proposed methods
Method A Method B
Gabantin-100 99.32 ± 1.04
98.27 ± 1.97
t = 1.05
F = 3.59
97.01 ± 2.24
t = 2.09
F = 4.64
Gabapin-300 98.07 ± 1.37
99.13 ± 1.88
t = 1.02
F = 1.88
98.96 ± 2.11
t = 0.79
F = 2.37
∗Mean value of ﬁve determinations.
Tabulated t-value at the 95% conﬁdence level is 2.78.
Tabulated F-value at the 95% conﬁdence level is 6.39.
precision of the proposed methods. Also, the accuracy of the
proposed methods was evaluated as percentage relative error
(RE%), and from the results shown in Table 4, it is clear that
the accuracy is good (RE ≤3.60%).
3.5.3. Selectivity. The selectivity of the proposed methods for
the analysis of GBP was evaluated by analysis of placebo8 International Journal of Analytical Chemistry
Table 7: Results of recovery study by standard addition method.
Capsules
studied
Method A Method B
GBP in
capsule,
μgmL −1
Pure GBP
added,
μgmL −1
Total found,
μgmL −1
Pure GBP
recovered∗,
Percent ± SD
GBP in
capsule,
μgmL −1
Pure GBP
added,
μgmL −1
Total found,
μgmL −1
Pure GBP
recovered∗,
Percent ± SD
Gabantin-100
4.91
4.91
4.91
2.50
5.00
7.50
7.36
9.95
12.36
98.00 ± 2.82
100.8 ± 1.96
99.33 ± 2.44
3.88
3.88
3.88
2.00
4.00
6.00
5.91
7.84
9.81
101.5 ± 1.74
99.01 ± 2.09
98.83 ± 2.62
Gabapin-300
5.95
5.95
5.95
3.00
6.00
9.00
9.00
11.84
15.17
101.7 ± 2.36
98.16 ± 2.28
102.4 ± 2.73
3.95
3.95
3.95
2.00
4.00
6.00
5.96
7.87
10.06
100.5 ± 2.41
98.02 ± 2.09
101.8 ± 2.18
blank solution as shown under “Procedure for capsules”,
and the resulting absorbance readings in both methods
were same as reagent blank, inferring no interference from
the placebo. Noninterference from placebo was further
conﬁrmed by carrying out recovery study from synthetic
mixture which with percent recoveries of 99.42 ± 2.05 and
98.56 ±2.43formethodAandmethodB,respectively.These
resultsconﬁrmtheselectivityoftheproposedmethodsinthe
presence of the commonly employed excipients added to the
formulations.
3.5.4. Robustness and Ruggedness. The evaluation of the
method robustness was done by making small incremental
changes in two experimental variables, reagent volume
and reaction time, and performing the analysis under the
altered experimental conditions. The eﬀect of the changes
on the absorbance reading of the resulted complexes in both
methods was studied and found to be negligible conﬁrming
the robustnessof the proposed methods. Method ruggedness
was expressed as %R.S.D of the same procedure applied
by three analysts and also by a single analyst performing
analysis on three diﬀerent instruments. The results presented
in Table 5 showed that no statistical diﬀerences between dif-
ferent analysts and instruments suggesting that the proposed
methods were rugged.
3.5.5. Analysis of Pharmaceutical Formulations. The pro-
posed methods were applied to the determination of GBP
in two representative capsules Gabantin-100 and Gabapin-
300. The results obtained are compiled in Table 6 and were
compared with those obtained by the reference method
[21] by means of Student’s t-test for accuracy and F-
tests for precision at 95% conﬁdence level. The reference
method consisted of the measurement of the absorbance
of the aqueous extract of the capsules at 210nm. As can
be seen from Table 6, the calculated t and F values at
95% conﬁdence level did not exceed the tabulated values
of 2.78 and 6.39, respectively, indicating that there were no
signiﬁcant diﬀerences between the proposed methods and
the reference method with respect to accuracy and precision.
3.6. Recovery Study. The accuracy and validity of the pro-
posed methods were further conﬁrmed by the standard
addition procedure. Preanalyzed capsule powder (Gabantin-
100 and Gabapin-300) was spiked with pure GBP at three
diﬀerent concentration levels (50, 100, and 150% of the
quantity present in the capsule powder), and the total was
analyzed by the proposed methods. The results of this study
are presented in Table 7 and indicate that the excipients
present in the capsules did not interfere in the assay.
4. Conclusions
Two simple, rapid, sensitive, and selective spectrophotomet-
ric methods have been proposed for the analysis of GBP in
pure form and in capsules. The proposed methods utilized
picric acid and 2,4-dinitrophenol as analytical reagents for
the determination of GBP based on the formation of ion-
pair complexes with the drug. From Sandell’s sensitivity
and LOD data presented in Table 3, it is clear that the
method A (using PA) is more sensitive than method B
(using 2,4-DNP). This is due to the fact that the proton of
the hydroxyl group in PA is more reactive or more acidic,
towards amino group of GBP, compared with the same
in 2,4-DNP. The high reactivity of the replaced proton in
PA than in 2,4-DNP can be attributed to the presence of
more number of electron-withdrawing (nitro) groups in PA.
The proposed methods are superior to all chromatographic
methods [6–11], most visible spectrophotometric methods
[16–19], and the automated spectrophotometric method
[22]r e p o r t e ds of a rf o ra n a l y s i so fG B Pi nt e r m so fi t s
sensitivity. Moreover, the proposed methods are free from
the usual analytical complications like heating or extraction
steps and use inexpensive and easily available chemicals and
instrument. Hence, the proposed methods can be readily
adopted by pharmaceutical quality control laboratory for
routine analysis.
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